Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile haemochromatosis

C Camaschella1

  • 1Dipartimento di Scienze Cliniche e Biologiche Università di Torino, Italy.

Bailliere'S Clinical Gastroenterology
|January 16, 1999
PubMed
Summary
This summary is machine-generated.

Juvenile hemochromatosis (JH) causes severe iron overload in young individuals. Early diagnosis and phlebotomy treatment are crucial to prevent life-threatening heart complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma.

Leukemia·2016
Same author

Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Reduces Pancytopenia After Rescue Therapy in a Patient with Hodgkin's Lymphoma.

Leukemia & lymphoma·2016
Same author

The mutual control of iron and erythropoiesis.

International journal of laboratory hematology·2016
Same author

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Natural history of recessive inheritance of DMT1 mutations.

The Journal of pediatrics·2007
Same author

Inherited hemochromatosis: from genetics to clinics.

Minerva medica·2005

Area of Science:

  • Genetics
  • Internal Medicine
  • Hematology

Background:

  • Juvenile hemochromatosis (JH) is an autosomal recessive disorder causing severe, early-onset iron overload.
  • Clinical features include endocrine dysfunction (hypogonadism) and heart failure, with less prominent liver involvement.
  • JH is genetically distinct from HFE-linked hemochromatosis, lacking HFE gene mutations.

Purpose of the Study:

  • To highlight the distinct nature of juvenile hemochromatosis (JH) compared to HFE-linked disease.
  • To emphasize the clinical significance of early diagnosis and treatment in JH.
  • To explore the potential for a different underlying biochemical defect in JH.

Main Methods:

  • Review of genetic evidence excluding HFE gene linkage in JH families.

Related Experiment Videos

  • Comparison of iron parameters and tissue distribution between JH and HFE-linked hemochromatosis.
  • Clinical observation of prominent endocrine and cardiac manifestations in JH.

    • Main Results:

    • Juvenile hemochromatosis (JH) patients lack HFE gene mutations and are not linked to chromosome 6p.
    • JH presents with severe iron overload, distinct endocrine and cardiac complications.
    • JH shares responsiveness to phlebotomy treatment with HFE-linked disease.

    Conclusions:

    • Juvenile hemochromatosis (JH) is a distinct genetic disorder from HFE-linked hemochromatosis.
    • Early diagnosis of JH is critical for preventing fatal cardiac complications.
    • Phlebotomy is an effective treatment for JH, similar to HFE-linked disease.